(Q38092840)

English

Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration

scientific article published on 25 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

0 references

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Robert Layfield

0 references

author name string

Nicolas Galazis

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Yik-Lam Pang

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Myria Galazi

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Zeina Haoula

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Robert Layfield

5

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

William Atiomo

6

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

publication date

25 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

638-644

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Long-term health consequences of PCOS.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Current concepts in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Polycystic ovary syndrome and endometrial carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Proteome and proteomics: new technologies, new concepts, and new words

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

FIGO staging of endometrial adenocarcinoma: a critical review and proposal

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Methodological deficits in diagnostic research using '-omics' technologies: evaluation of the QUADOMICS tool and quality of recently published studies

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Mitochondrial dysfunction in type 2 diabetes and obesity

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Expression of metabolically targeted biomarkers in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Subtractive proteomic approach to the endometrial carcinoma invasion front.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry.

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Complement: a unique innate immune sensor for danger signals

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Cyclophilin A is a proinflammatory cytokine that activates endothelial cells

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Transgelin: an actin-binding protein and tumour suppressor

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Pyruvate kinase type M2 and its role in tumor growth and spreading

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.777416

21 January 2018

Identifiers

10.3109/09513590.2013.777416

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38092840&oldid=2114312679"